Cargando…

PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies

Detalles Bibliográficos
Autores principales: Guillen Astete, CA, García Campayo, L, Conde Campayo, B, Sifuentes Giraldo, A, Gamir Gamir, ML
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045607/
http://dx.doi.org/10.1186/1546-0096-11-S2-P46
_version_ 1782319351003611136
author Guillen Astete, CA
García Campayo, L
Conde Campayo, B
Sifuentes Giraldo, A
Gamir Gamir, ML
author_facet Guillen Astete, CA
García Campayo, L
Conde Campayo, B
Sifuentes Giraldo, A
Gamir Gamir, ML
author_sort Guillen Astete, CA
collection PubMed
description
format Online
Article
Text
id pubmed-4045607
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40456072014-06-20 PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies Guillen Astete, CA García Campayo, L Conde Campayo, B Sifuentes Giraldo, A Gamir Gamir, ML Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4045607/ http://dx.doi.org/10.1186/1546-0096-11-S2-P46 Text en Copyright © 2013 Guillen Astete et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Guillen Astete, CA
García Campayo, L
Conde Campayo, B
Sifuentes Giraldo, A
Gamir Gamir, ML
PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
title PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
title_full PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
title_fullStr PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
title_full_unstemmed PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
title_short PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
title_sort pres-final-2033: increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045607/
http://dx.doi.org/10.1186/1546-0096-11-S2-P46
work_keys_str_mv AT guillenasteteca presfinal2033increaseofadversemildandmoderateadverseeventsamongpatientswithjuvenileidiopathicarthritistreatedwithbiologicaltherapies
AT garciacampayol presfinal2033increaseofadversemildandmoderateadverseeventsamongpatientswithjuvenileidiopathicarthritistreatedwithbiologicaltherapies
AT condecampayob presfinal2033increaseofadversemildandmoderateadverseeventsamongpatientswithjuvenileidiopathicarthritistreatedwithbiologicaltherapies
AT sifuentesgiraldoa presfinal2033increaseofadversemildandmoderateadverseeventsamongpatientswithjuvenileidiopathicarthritistreatedwithbiologicaltherapies
AT gamirgamirml presfinal2033increaseofadversemildandmoderateadverseeventsamongpatientswithjuvenileidiopathicarthritistreatedwithbiologicaltherapies